BMY 7378 dihydrochloride

• CAT Number: I010354
• CAS Number: 21102-95-4
• Molecular Formula: C22H33Cl2N3O3
• Molecular Weight: 458.42
• Purity: ≥95%
• Synonyms: 8-[2-[4-(methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride
• Target: Neuronal Signaling
• Solubility: Soluble to 100 mM in water
• Storage: Store at RT
• IUPAC Name: 8-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-8-azaspiro[4.5]decane-7,9-dione;dihydrochloride
• InChI: InChI=1S/C22H31N3O3.2ClH/c1-28-19-7-3-2-6-18(19)24-13-10-23(11-14-24)12-15-25-20(26)16-22(17-21(25)27)8-4-5-9-22;;/h2-3,6-7H,4-5,8-17H2,1H3;2*1H
• InChIKey: NIBOMXUDFLRHRV-UHFFFAOYSA-N
• SMILES: COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O.Cl.Cl

BMY 7378 dihydrochloride（Cat No.:I010354）is a selective antagonist of the serotonin 5-HT2C receptor, a subtype of the serotonin receptor family involved in various neurological and psychiatric functions. This compound has been studied for its potential in treating disorders like depression, anxiety, and obesity. By blocking the 5-HT2C receptor, BMY 7378 dihydrochloride may alter serotonin signaling, improving mood regulation and appetite control. Preclinical and early clinical studies suggest its potential therapeutic benefits, though further research is necessary to assess its safety, efficacy, and long-term effects in human patients.